SEC 13F Intelligence

Northeast Investment Management / LLY

Northeast Investment Management’s Eli Lilly & Co Position

Does Northeast Investment Management own Eli Lilly & Co (LLY)? Yes — 54.0K shares worth $50M (+2.06% of its 13F portfolio) as of Q1 2026, up from 54.0K shares the prior filed quarter.

Position Value
$50M
Q1 2026
Shares
54.0K
% of Portfolio
+2.06%
Quarters Held
30
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $1MQ4 ’18Q1 ’19: $1MQ2 ’19: $1MQ3 ’19: $1MQ4 ’19: $1MQ4 ’19Q1 ’20: $1MQ2 ’20: $2MQ3 ’20: $2MQ4 ’20: $2MQ4 ’20Q1 ’21: $2MQ2 ’21: $2MQ3 ’21: $2MQ4 ’21: $3MQ4 ’21Q1 ’22: $3MQ2 ’22: $4MQ3 ’22: $5MQ4 ’22: $5,884Q4 ’22Q1 ’23: $6MQ2 ’23: $14MQ3 ’23: $19MQ4 ’23: $24MQ4 ’23Q1 ’24: $36MQ2 ’24: $46MQ3 ’24: $45MQ4 ’24: $41MQ4 ’24Q1 ’25: $46MQ2 ’25: $43MQ3 ’25: $41MQ4 ’25: $58MQ4 ’25Q1 ’26: $50Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202654.0K$50M+2.06%
Q4 202554.0K$58M+2.27%
Q3 202554.1K$41M+1.66%
Q2 202554.6K$43M+1.82%
Q1 202555.5K$46M+2.14%
Q4 202453.5K$41M+1.83%
Q3 202451.3K$45M+2.03%
Q2 202450.5K$46M+2.15%
Q1 202446.7K$36M+1.78%
Q4 202341.3K$24M+1.29%
Q3 202335.7K$19M+1.13%
Q2 202329.7K$14M+0.79%
Q1 202317.1K$6M+0.36%
Q4 202216.1K$5,884+0.37%
Q3 202214.8K$5M+0.32%
Q2 202213.4K$4M+0.28%
Q1 202211.6K$3M+0.17%
Q4 20219.8K$3M+0.13%
Q3 202110.4K$2M+0.13%
Q2 202110.4K$2M+0.13%
Q1 202110.7K$2M+0.12%
Q4 202010.6K$2M+0.11%
Q3 202010.7K$2M+0.10%
Q2 202010.7K$2M+0.13%
Q1 202010.6K$1M+0.13%
Q4 201911.0K$1M+0.11%
Q3 201911.0K$1M+0.10%
Q2 201911.2K$1M+0.10%
Q1 201911.3K$1M+0.12%
Q4 201811.5K$1M+0.13%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Northeast Investment Management’s full portfolio or all institutional holders of LLY.